田中精機(300461.SZ):張玉龍擬受讓6%的股份
格隆匯6月8日丨田中精機(300461.SZ)公佈,公司控股股東、實際控制人竹田享司、竹田周司擬將其合計持有的公司326.9722萬股非限售流通股票(佔公司總股本的2.69%)協議轉讓給張玉龍;
公司持股5%以上股東、董事長錢承林擬將其持有的公司223.8812萬股非限售流通股票(佔公司總股本的1.84%)協議轉讓給張玉龍;
公司持股5%以上股東、董事、副總經理藤野康成擬將其持有的公司179.1466萬股非限售流通股票(佔公司總股本的1.47%)協議轉讓給張玉龍。
轉讓完成後,張玉龍將持有公司6.00%股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.